NWPF

News ArchivesRead News

More Benefits Found In Deep Brain Stimulation for Parkinson’s

Thursday June 26, 2014

Rick Nauert, PhD

PsychCentral - While it is well-recognized that deep brain stimulation (DBS) improves motor symptoms of patients with early and advanced Parkinson’s disease (PD), new research finds that DBS also reduces the number and severity of non motor symptoms.

“Non-motor features are common in PD patients, occur across all disease stages, and while well-described, are still under-recognized when considering their huge impact on patients’ quality of life,” said Lisa Klingelhoefer, M.D.

For example, DBS of the subthalamic nucleus (STN) is effective for alleviating sleep problems and fatigue associated with PD, producing noticeable long-term improvements in sleep efficiency and the quality and duration of continuous sleep.

DBS also decreases nighttime and early morning dystonia and improves nighttime mobility.

“DBS can contribute to better sleep, less daytime somnolence, improved mobility, and less need for dopamine replacement therapy,” said Klingelhoefer.

Emerging evidence now indicates that DBS can decrease the number and severity of non motor symptoms of patients with Parkinson’s disease (PD) as well, according to a review published in the Journal of Parkinson’s Disease.

However, the effects of DBS on some other non-motor symptoms of PD are less clear-cut, and transient worsening of neuropsychological and psychiatric symptoms have been reported.

For instance, behavioral disorders such as impulsivity (e.g. hypersexuality, pathological gambling, and excessive eating) can occur or worsen in PD patients after STN DBS.

While pre-existing drug-induced psychotic symptoms like hallucinations often disappear after STN DBS, transient psychotic symptoms such as delirium may emerge in the immediate post-operative period.

Similarly, conflicting reports have found that STN DBS improves, worsens, or does not change mood disorders such as depression,mania, or anxiety.

“Further work is required in order to fully understand the mechanisms and impact of DBS of the STN or other brain structures on the non-motor symptoms of PD,” concluded Klingelhoefer.

She suggests that in the future, non-motor symptoms of PD may become an additional primary indication for DBS.

Nauert, Rick PhD. (26 June 2014). More Benefits Found In Deep Brain Stimulation for Parkinson’s. http://psychcentral.com/news/2014/06/26/more-benefits-found-in-deep-brain-stimulation-for-parkinsons/71734.html

Recent News

Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement
Jul 19 - What Young-onset Parkinson’s Can Look Like
Jul 7 - Parkinson’s Patients Have a Higher Risk of Developing Melanoma — and Vice Versa, Study Finds
Jun 27 - The rogue protein behind Parkinson’s disease may also protect your gut
Jun 26 - Do Statins Increase Risk of Parkinson’s Disease? Some Researchers Think So
Jun 22 - A Confused Immune System Could Be Behind Parkinson's Disease
Jun 21 - Predicting cognitive deficits in people with Parkinson’s disease
Jun 20 - Gym offers classes in noncontact boxing for Parkinson’s patients
Jun 19 - Human Limitations Could Prevent Us From Advancing in Science. AI Could Help.
Jun 13 - Brain Cell Transplants Are Being Tested Once Again For Parkinson's
Jun 12 - Smell Test May Sniff Out Oncoming Parkinson's and Alzheimer's
Jun 8 - Smartphones Track Motor Function in Parkinson's Disease
Jun 8 - GKC Enrolls First Patient in Personal KinetiGraph Trial as Part of NPF’s Parkinson’s Outcomes Project